XTLB
HEALTHCAREX.T.L. Biopharmaceuticals Ltd
$3.25-0.41 (-11.20%)LIVE
Live · NASDAQ · May 9, Close
AI Insight
What's Moving XTLB Today?
No stock-specific AI insight has been generated for XTLB yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$2.12$10.28
$3.25
Fundamentals
Market Cap$8M
P/E Ratio—
EPS$-3.60
Dividend Yield—
Dividend / Share—
ROE-5.8%
Profit Margin—
Debt / Equity—
Trading
Volume127K
Avg Volume (10D)—
Shares Outstanding2.4M
XTLB News
9 articles- XTL Biopharmaceuticals to Acquire Psyga Bio, Establishing a Leading Psychedelic Biotechnology Platform with Advanced Clinical Pipeline, Licensed GMP Manufacturing and Proprietary Psilocybin TechnologiesYahoo Finance·Apr 29, 2026
- XTL Biopharmaceuticals Announces ADS Ratio ChangeYahoo Finance·Mar 20, 2026
- XTL Announces Receipt of Staff Delist Determination from Nasdaq and Plans to Request HearingYahoo Finance·Feb 27, 2026
- XTL Update on Recent DevelopmentsYahoo Finance·Jan 29, 2026
- XTL Announces Receipt of Nasdaq Notification Regarding Minimum Stockholders’ Equity DeficiencyYahoo Finance·Jan 23, 2026
- Top Midday GainersYahoo Finance·Jan 13, 2026
- XTL Biopharmaceuticals Acquires 85% of NeuroNOS, Entering the Massive Autism Market with Nobel Prize-Winning Scientific LeadershipYahoo Finance·Jan 13, 2026
- XTL Biopharmaceuticals Acquires 85% of Beyond Air’s Subsidiary NeuroNOS, Entering the Massive Autism Market with Nobel Prize-Winning Scientific LeadershipYahoo Finance·Jan 13, 2026
- XTL Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price DeficiencyYahoo Finance·Dec 24, 2025
All 9 articles loaded
Price Data
Open$3.53
Previous Close$3.66
Day High$4.01
Day Low$3.51
52 Week High$10.28
52 Week Low$2.12
52-Week Range
$2.12$10.28
$3.25
Fundamentals
Market Cap$8M
P/E Ratio—
EPS$-3.60
Dividend Yield—
Dividend / Share—
ROE-5.8%
Profit Margin—
Debt / Equity—
Trading
Volume127K
Avg Volume (10D)—
Shares Outstanding2.4M
About X.T.L. Biopharmaceuticals Ltd
XTL Biopharmaceuticals Ltd., a biopharmaceutical company, is engaged in the acquisition and development of pharmaceutical products for the treatment of autoimmune diseases. The company is headquartered in Ramat Gan, Israel.
HEALTHCAREBIOTECHNOLOGY
Company Details
Security TypeStock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICBIOTECHNOLOGY
CIK—
Composite FIGI—
Share Class FIGI—